483 BRI Institutional Review Board Feb 2013

483 BRI Institutional Review Board Feb 2013

Andrea Branche FDA$119.00 - Available Now

FDA investigators audited the BRI Institutional Review Board - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 07 Feb 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Feb 2013
  • Location: Houston, United States
  • FEI: 1000220451
Add To Cart